Pharmaceutical composition for preventing or treating muscle weakness diseases comprising Acecainide or derivatives thereof

摘要

The present invention relates to a composition for promoting the differentiation of myoblasts comprising acecainide or a derivative thereof, Procainamide, or a pharmaceutically acceptable salt thereof, a composition for accelerating the differentiation of acecainide or its derivative A method for promoting differentiation of a source cell, which comprises treating an extracorporeal cell with a derivative of procainamide (Procainamide) or a pharmaceutically acceptable salt thereof, a process for promoting the differentiation of a source cell, such as procainamide or a derivative thereof, ), Or a pharmaceutically acceptable salt thereof, to an extracorporeal source cell to differentiate a source cell, a method of producing a differentiated source cell comprising the step of administering to a patient a prophylactic agent selected from the group consisting of Acecainide or its derivative Procainamide, , / RTI or a pharmaceutically acceptable salt thereof, for the prophylaxis or treatment of muscular weakness related to muscular weakness A food composition for preventing or ameliorating muscular weakness related to muscular and muscular weakness, procainamide, or a derivative thereof, or a pharmaceutically acceptable salt thereof, to an individual in need thereof To a method for treating muscular weakness related to muscle weakness. Procainamide, acecainide or its derivative, according to the present invention can promote root differentiation and root canal formation, thereby preventing muscle weakness and effectively improving muscle function . Accordingly, the pharmaceutical composition containing the same can be usefully used for the prevention or treatment of muscular weakening-related diseases.